CoreWeave CEO Stands Firm on $9B Core Scientific Offer as Shareholder Opposition Mounts

Core Viewpoint - CoreWeave's CEO stated that the company will not increase its $9 billion all-stock offer for Core Scientific, emphasizing that the acquisition is not essential and reflects the relative value of both companies [1] Group 1: Acquisition Details - CoreWeave proposed an all-stock deal for Core Scientific at $20.40 per share [2] - The acquisition is described as a "nice to have, not a need to have" by CoreWeave's CEO [1] Group 2: Shareholder Reactions - Institutional Shareholder Services (ISS) recommended shareholders reject the acquisition, arguing that Core Scientific can continue to grow independently [2] - Two Seas Capital, a Core Scientific investor, is leading opposition against the deal, citing flaws in the sale process and deal structure [3] Group 3: Market Response - CoreWeave's stock decreased by 4.3% while Core Scientific's stock increased by 1.6%, indicating market preference for Core Scientific's independence [3]